BioMarin Pharmaceutical Inc. buy Barclays PLC
Start price
06.08.24
/
50%
€79.46
Target price
06.08.25
€100.74
Performance (%)
6.14%
Price
20.08.24
€84.34
Summary
This prediction is currently active. With a performance of 6.14%, the BUY prediction by Barclays_PLC for BioMarin Pharmaceutical Inc. is trending in the right direction. This prediction currently runs until 06.08.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
BioMarin Pharmaceutical Inc. | 3.688% |
iShares Core DAX® | 3.126% |
iShares Nasdaq 100 | 3.003% |
iShares Nikkei 225® | 4.991% |
iShares S&P 500 | 1.852% |
Comments by Barclays_PLC for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Barclays PLC from $111.00 to $110.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat